AC Immune SA is clinical-stage biopharmaceutical company that aims to become a global leader in precision medicine for neurodegenerative diseases, including Alzheimer’s disease, Parkinson’s disease, and NeuroOrphan indications driven by misfolded proteins. The Company’s two clinically validated technology platforms, SupraAntigen™ and Morphomer™, fuel its broad and diversified pipeline of first- and best-in-class assets, which currently features nine therapeutic and three diagnostic candidates, six of which are currently in clinical trials. AC Immune has a strong track record of securing strategic partnerships with leading global pharmaceutical companies including Genentech, a member of the Roche Group, Eli Lilly and Company, and Janssen Pharmaceuticals, Inc., resulting in substantial non-dilutive funding to advance its proprietary programs and >$3 billion in potential milestone payments.



Biotechnology

AC Immune

AC Immune's headquarters in Lausanne, Switzerland

This department focuses on the development and innovation of antibody-based therapies and technologies.

Antibody Engineering

The Scientific & Research Team at AC Immune is responsible for developing and advancing the company’s pipeline of therapeutic and diagnostic candidates targeting neurodegenerative diseases. This multidisciplinary team combines expertise in drug discovery, clinical research, data science, and preclinical development to support the company's innovative platforms, SupraAntigen™ and Morphomer™. They collaborate closely with strategic partners to accelerate the progression of treatments through clinical trials, ensuring rigorous scientific validation at every stage.

Scientific & Research Team

This department focuses on conducting research and providing analytical support across various projects.

Research Department

The Leadership Team at AC Immune is responsible for setting the strategic vision and direction of the company, ensuring alignment across departments to advance its pipeline of innovative therapies for neurodegenerative diseases. This diverse group of executives, including the Chief Financial Officer, Chief Human Resources Officer, and Chief Scientific Officer, works collaboratively to oversee operations, regulatory compliance, and talent management, while fostering partnerships and securing funding to enhance the company’s research and development efforts.

Leadership Team

The Finance Team at AC Immune SA is responsible for managing the company's financial health and ensuring efficient financial operations. This includes budgeting, financial planning, and analysis, as well as maintaining accurate financial records and ensuring compliance with regulatory requirements. The team also handles financial reporting, internal controls, accounts payable, and strategic financial decision-making to support the company's business objectives and partnerships.

Finance Team

The Clinical Operations Team at AC Immune is responsible for planning, executing, and overseeing clinical trials for the company's neurodegenerative disease therapies and diagnostics. This team ensures that clinical studies are conducted in compliance with regulatory standards and within timelines and budget, managing everything from trial design and site selection to patient recruitment and data collection, ultimately supporting the Company's goal to advance its therapeutic candidates through the clinical pipeline.

��

People (5)

Jobs (0)

Other teams

Scientific & Research Team

Research Department

Leadership Team

Finance Team

Clinical Operations Team

��������

People (5)

Jobs (0)

Other teams

Scientific & Research Team

Research Department

Leadership Team

Finance Team

Clinical Operations Team

��